Preliminary Results of TQB2450 (PD-L1 Blockade) Plus Anlotinib Combined with Oxaliplatin and Capecitabine in the First-Line Treatment of Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma: A Single-Arm, Multicenter Phase II Clinical Trial.
JOURNAL OF CLINICAL ONCOLOGY（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined